CLLS · Cellectis S.A.
$3.05
-0.13 (-4.09%)
At close · Aug 14
Market Cap
$307.13M
Shares
100.70M
Cellectis S.A. Earnings Call Transcripts
Every quarterly earnings call for Cellectis S.A. (CLLS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Conference
Investor event
2026-09-15
2026 Baird’s Global Healthcare Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-08
Wells Fargo 21st Annual Healthcare Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-06-25
Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-06-25
Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q2
2025-06-30
Cellectis S.A. Q2 FY2025 Earnings Call
Confident tone
Servier / Allogene arbitration
Regulatory interactions (FDA / EMA)
Lasme-cel / UCART22 BALLI-01 in r/r B-ALL
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Cellectis S.A. Q4 FY2024 Earnings Call
Confident tone
AstraZeneca partnership and equity investment
Competitive landscape and CARGO setback
Allogeneic CAR T durability / ALLO-501A data
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Cellectis S.A. Q3 FY2024 Earnings Call
Confident tone
BALLI-01 / UCART22 clinical trial
AstraZeneca collaboration
Phase II regulatory strategy
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Cellectis S.A. Q1 FY2024 Earnings Call
Confident tone
AstraZeneca partnership and equity investment
BALLI-01 trial in ALL
NatHaLi-01 trial in B-cell NHL
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2023-09-30
Cellectis S.A. Q3 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Cellectis S.A. Q2 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Cellectis S.A. Q1 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Cellectis S.A. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Cellectis S.A. Q3 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Cellectis S.A. Q2 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Cellectis S.A. Q1 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Cellectis S.A. Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Cellectis S.A. Q3 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Cellectis S.A. Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Cellectis S.A. Q1 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–19 of 19 earnings calls
Key facts
CIK
1627281
CUSIP
15117K103
13F (30d)
25 filings
25 filers
Visit website
Investor relations